These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33827901)

  • 1. Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups.
    Narasimhan M; Mahimainathan L; Araj E; Clark AE; Markantonis J; Green A; Xu J; SoRelle JA; Alexis C; Fankhauser K; Parikh H; Wilkinson K; Reczek A; Kopplin N; Yekkaluri S; Balani J; Thomas A; Singal AG; Sarode R; Muthukumar A
    J Clin Microbiol; 2021 Jun; 59(7):e0038821. PubMed ID: 33827901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST).
    Narasimhan M; Mahimainathan L; Araj E; Clark AE; Wilkinson K; Yekkaluri S; Tiro J; Lee FM; Balani J; Sarode R; Singal AG; Muthukumar A
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33924340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand.
    Permpikul P; Tongyoo S; Chaimayo C; Kanpai P; Virat J; Virat S; Chuchaaim J; Thongput A; Bhatnagar S
    PLoS One; 2023; 18(5):e0285737. PubMed ID: 37200273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests.
    Maine GN; Krishnan SM; Walewski K; Trueman J; Sykes E; Sun Q
    J Immunol Methods; 2022 Apr; 503():113243. PubMed ID: 35181288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
    Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
    Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines.
    Narasimhan M; Mahimainathan L; Clark AE; Usmani A; Cao J; Araj E; Torres F; Sarode R; Kaza V; Lacelle C; Muthukumar A
    Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34208884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
    Takahashi M; Ai T; Sinozuka K; Baba Y; Igawa G; Nojiri S; Yamamoto T; Yuri M; Takei S; Saito K; Horiuchi Y; Kanno T; Tobiume M; Khasawneh A; Paran FJ; Hiki M; Wakita M; Miida T; Suzuki T; Okuzawa A; Takahashi K; Naito T; Tabe Y
    Sci Rep; 2022 Sep; 12(1):14909. PubMed ID: 36050347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination.
    Oktelik FB; Yilmaz V; Gelmez MY; Akdeniz N; Pamukcu C; Sutlu T; Kose M; Tuzun E; Deniz G
    Can J Microbiol; 2022 Aug; 68(8):543-550. PubMed ID: 35852365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
    Turbett SE; Anahtar M; Dighe AS; Garcia Beltran W; Miller T; Scott H; Durbin SM; Bharadwaj M; Thomas J; Gogakos TS; Astudillo M; Lennerz J; Rosenberg ES; Branda JA
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33020186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.
    Ruggiero A; Piubelli C; Calciano L; Accordini S; Valenti MT; Carbonare LD; Siracusano G; Temperton N; Tiberti N; Longoni SS; Pizzato M; Accordini S; ; Fantoni T; Lopalco L; Beretta A; Bisoffi Z; Zipeto D
    EBioMedicine; 2022 Mar; 77():103888. PubMed ID: 35196644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.